Decreasing glutamate buffering capacity triggers oxidative stress and neuropil degeneration in the Drosophila brain

Current Biology

Volumn 14, Issue 7, 2004, Pages 599-605

  Rival, Thomas ^a   Soustelle, Laurent ^a   Strambi, Colette ^a   Besson, Marie Thérèse ^a   Iché, Magali ^a   Birman, Serge ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; MELATONIN; PARAQUAT; PRIMER DNA; RILUZOLE;

ANIMAL; ARTICLE; BRAIN; COMPARATIVE STUDY; DROSOPHILA; DRUG EFFECT; FLUORESCENCE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MOVEMENT (PHYSIOLOGY); NERVE DEGENERATION; NEUROPIL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; BRAIN; DNA PRIMERS; DROSOPHILA; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; FLUORESCENCE; GENE SILENCING; GLUTAMIC ACID; HUMANS; MELATONIN; MICROSCOPY, ELECTRON, SCANNING; MOVEMENT; NERVE DEGENERATION; NEUROPIL; OXIDATIVE STRESS; PARAQUAT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RILUZOLE; RNA INTERFERENCE;

ANIMALIA; INSECTA; MAMMALIA;

EID: 1842816630     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2004.03.039     Document Type: Article

References (38)

1. Fonnum F. Glutamate. a neurotransmitter in mammalian brain J. Neurochem. 42:1984;1-11.
2. Nicholls D.G. The glutamatergic nerve terminal. Eur. J. Biochem. 212:1993;613-631.
3. Olney J.W., Ho O.L. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature. 227:1970;609-611.
4. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
5. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399:1999;A7-14.
6. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 403:2000;316-321.
7. Doble A. The role of excitotoxicity in neurodegenerative disease. implications for therapy Pharmacol. Ther. 81:1999;163-221.
8. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig. deciphering selective motor neuron death in ALS Nat. Rev. Neurosci. 2:2001;806-819.
9. Heath P.R., Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve. 26:2002;438-458.
10. Seal R.P., Daniels G.M., Wolfgang W.J., Forte M.A., Amara S.G. Identification and characterization of a cDNA encoding a neuronal glutamate transporter from Drosophila melanogaster. Receptors Channels. 6:1998;51-64.
11. Besson M.T., Soustelle L., Birman S. Identification and structural characterization of two genes encoding glutamate transporter homologues differently expressed in the nervous system of Drosophila melanogaster. FEBS Lett. 443:1999;97-104.
12. Besson M.T., Soustelle L., Birman S. Selective high-affinity transport of aspartate by a Drosophila homologue of the excitatory amino-acid transporters. Curr. Biol. 10:2000;207-210.
13. Soustelle L., Besson M.T., Rival T., Birman S. Terminal glial differentiation involves regulated expression of the excitatory amino acid transporters in the Drosophila embryonic CNS. Dev. Biol. 248:2002;294-306.
14. Kennerdell J.R., Carthew R.W. Heritable gene silencing in Drosophila using double-stranded RNA. Nat. Biotechnol. 18:2000;896-898.
15. Friggi-Grelin F., Coulom H., Meller M., Gomez D., Hirsh J., Birman S. Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase. J. Neurobiol. 54:2003;618-627.
16. Schulte J., Tepass U., Auld V.J. Gliotactin, a novel marker of tricellular junctions, is necessary for septate junction development in Drosophila. J. Cell Biol. 161:2003;991-1000.
17. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14:1994;5559-5569.
18. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1995;357-366.
19. Reiter R.J. Oxidative damage in the central nervous system. protection by melatonin Prog. Neurobiol. 56:1998;359-384.
20. Lin Y.J., Seroude L., Benzer S. Extended life-span and stress resistance in the Drosophila mutant methuselah. Science. 282:1998;943-946.
21. Parkes T.L., Elia A.J., Dickinson D., Hilliker A.J., Phillips J.P., Boulianne G.L. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat. Genet. 19:1998;171-174.
22. Phillips J.P., Campbell S.D., Michaud D., Charbonneau M., Hilliker A.J. Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc. Natl. Acad. Sci. USA. 86:1989;2761-2765.
23. Kirby K., Hu J., Hilliker A.J., Phillips J.P. RNA interference-mediated silencing of Sod2 in Drosophila leads to early adult-onset mortality and elevated endogenous oxidative stress. Proc. Natl. Acad. Sci. USA. 99:2002;16162-16167.
24. Jaarsma D., Rognoni F., van Duijn W., Verspaget H.W., Haasdijk E.D., Holstege J.C. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol. (Berl.). 102:2001;293-305.
25. Bendotti C., Calvaresi N., Chiveri L., Prelle A., Moggio M., Braga M., Silani V., De Biasi S. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J. Neurol. Sci. 191:2001;25-33.
26. Dauer W., Przedborski S. Parkinson's disease. mechanisms and models Neuron. 39:2003;889-909.
27. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death. a succession of necrosis or apoptosis depending on mitochondrial function Neuron. 15:1995;961-973.
28. Schinder A.F., Olson E.C., Spitzer N.C., Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16:1996;6125-6133.
29. Stout A.K., Raphael H.M., Kanterewicz B.I., Klann E., Reynolds I.J. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1:1998;366-373.
30. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P.et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 16:1996;675-686.
31. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T.et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science. 276:1997;1699-1702.
32. Ultsch A., Schuster C.M., Laube B., Betz H., Schmitt B. Glutamate receptors of Drosophila melanogaster. Primary structure of a putative NMDA receptor protein expressed in the head of the adult fly. FEBS Lett. 324:1993;171-177.
33. Volkner M., Lenz-Bohme B., Betz H., Schmitt B. Novel CNS glutamate receptor subunit genes of Drosophila melanogaster. J. Neurochem. 75:2000;1791-1799.
34. Rothstein J.D., Martin L.J., Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326:1992;1464-1468.
35. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 18:1997;327-338.
36. Ludolph A.C., Meyer T., Riepe M.W. The role of excitotoxicity in ALS-what is the evidence? J. Neurol. 247(Suppl 1):2000;I7-16.
37. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med. 330:1994;585-591.
38. Lacomblez L., Bensimon G., Leigh P.N., Guillet P., Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 347:1996;1425-1431.